NY Times online columnist David Bornstein examines how the Cure Alzheimer's Fund and other organizations have taken a unique approach to research that is intensely goal-directed and collaborative, focusing on the creation of new cures and potential treatment as a process that needs to be managed. Bornstein notes the Fund has worked to bring a sense of urgency to their research that is resulted oriented.
NY Times online column highlights Cure Alzhemer's Fund's innovative approach to research
Posted: May 16, 2011
© 2005-2017 Cure Alzheimer's Fund. All rights reserved.